Pyridopyrazine derivatives, process of manufacturing and uses thereof

US8507486B2 · kind B2 · utility

Assignee

• Aeterna Zentaris, Inc. · DE

Inventors

• Matthias Gerlach · Wächtersbach, DE
• Irene Seipelt · Offenbach, DE
• Eckhard Guenther · Maintal, DE
• Emmanuel Polymeropoulos · Frankfurt, DE
• Tilmann Schuster · Großostheim, DE
• Eckhard Claus · Frankfurt, DE

Key dates

• Filing date: Apr 25, 2012
• Grant date: Aug 13, 2013
• Expiry date: Apr 25, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-b]pyrazine-6-yl]thiourea which HAS activity to the modulation of misdirected cellular signal transduction processes such as tyrosine kinases, serine/threonine kinases and/or lipid kinases.